医疗技术公司Senseonics Holdings（SENS）今日盘前大涨5.13%，引发市场关注。这一涨幅主要源于公司最新发布的融资消息。
据悉，Senseonics昨日晚间以每股0.50美元的价格发行了1亿股股票，共筹集5000万美元资金。同时，制药巨头雅培实验室（Abbott Laboratories）参与了一项私募投资，以相同价格购买了价值高达2500万美元的股票，这使得雅培将持有Senseonics约5%的股份。
Senseonics表示，将利用这笔资金继续推进其Eversense 365连续血糖监测系统的商业化，并进一步开发其产品线。此外，公司还终止了此前与高盛达成的5500万美元场内股权销售协议。这些举措显示出公司正在积极调整其融资策略，以支持未来的发展计划。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.